Phase III clinical trial programme for KD 019
Latest Information Update: 13 Nov 2007
At a glance
- Drugs Tesevatinib (Primary)
- Indications Cancer
- Focus Registrational; Therapeutic Use
- Sponsors Exelixis
- 13 Nov 2007 New trial record.
Latest Information Update: 13 Nov 2007